mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.5 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.5 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |